Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Palmoplantar pustulosis o se ma'i pustular dermatosis faifaipea (o lona uiga, o le pustulosis po'o le pustular psoriasis) o lo'o i luga o alofilima ma alofolima na'o, e fa'ailoa i le histology i totonu o le epidermal pustules ua tumu i neutrophils. Retinoid systemic, na'o ia po'o le fa'atasi ma le photochemotherapy, e mafai ona fa'aleleia ai fa'amaoni o palmoplantar pustulosis.

○ Togafiti
Acitretin oral e aoga mo lenei ituaiga psoriasis.
#Acitretin
☆ AI Dermatology — Free Service
I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
  • I lenei tulaga, pompholyx e mafai foi ona masalomia.
  • I le leai o pustules, eczema lima e mafai foi ona manatu o se suʻesuʻega eseese.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar pustulosis o se ituaiga o pustulosis (pustulosis palmaris et plantaris) e a'afia tele le pa'u o le alofilima ma alofivae. E fa'aalia e pei o le hyperkeratotic (hyperkeratotic), le pustular, po'o le tu'ufa'atasiga o ituaiga uma e lua.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).